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ABSTRACT
Purpose Miscibility of the different compounds that make up a
solid dispersion based formulation play a crucial role in the drug
release profile and physical stability of the solid dispersion as it
defines the phase behaviour of the dispersion. The standard
technique to obtain information on phase behaviour of a sample
is (modulated) differential scanning calorimetry ((M)DSC). How-
ever, for ternary mixtures (M)DSC alone is not sufficient to
characterize their phase behaviour and to gain insight into the
distribution of the active pharmaceutical ingredient (API) in a two-
phased polymeric matrix.
Methods MDSC was combined with complementary surface
analysis techniques, specifically time-of-flight secondary ion mass
spectrometry (ToF-SIMS) and atomic force microscopy (AFM).
Three spray-dried model formulations with varying API/PLGA/
PVP ratios were analyzed.
Results MDSC, TOF-SIMS and AFM provided insights into dif-
ferences in drug distribution via the observed surface coverage for
3 differently composed ternary solid dispersions.
Conclusions Combining MDSC and surface analysis rendered
additional insights in the composition of mixed phases in complex
systems, like ternary solid dispersions.
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ABBREVIATIONS
MDSC Modulated differential scanning calorimetry
AFM Atomic force microscopy
API Active pharmaceutical ingredient
DDS Drug delivery system
HIV Human immunodeficiency virus
PLGA Poly(lactic-co-glycolic acid)
PVP Polyvinylpyrrolidone
Tg Glass transition temperature
ToF-SIMS Time of flight secondary ion mass spectrometry
INTRODUCTION
Solid dispersions are an intensively investigated enabling tech-
nology to formulate poorly soluble drugs so as to improve their
bioavailability [1–5]. Phase behaviour of the different com-
pounds plays a crucial role in this type of formulation as it will
determine whether a given drug-polymer combination will be
present as a glass solution (molecular dispersion) or a phase
separated system (amorphous-amorphous or amorphous-
crystalline phase separation). Hence, the phase behaviour will
have an influence on the release profile and stability perfor-
mance of such a formulation. The technique of (modulated)
differential scanning calorimetry ((M)DSC) is generally used to
study the phase behaviour and miscibility of a drug delivery
system (DDS). Based upon the experimentally observed glass
transition temperatures (Tgs) the phase behaviour and compo-
sition of binary drug-polymer mixtures can be estimated by a
number of expressions such as the Gordon-Taylor, Fox or
Couchman-Karasz equation. All of these equations are math-
ematical derivations on the same theme and were originally
developed for ideal binary polymer systems [6]. For binary
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pharmaceutical samples the Gordon-Taylor equation is the
most frequently used expression to describe the relationship
between the Tg and sample composition [7]. A similar expres-
sion for ternary mixtures has been developed but finds limited
application due to the contradiction between the complexity of
ternary mixtures and the assumptions made for this model
equation [6]. Therefore for ternary mixtures (M)DSC alone is
not sufficient to characterize the composition of the different
phases present, as for a mixed phase it is virtually impossible to
determine the weight fraction of each of the three compounds.
Knowledge of the composition of the different phases would
inform on the distribution of a drug throughout the DDS.
Inhomogeneous drug distribution, such as surface enrichment,
can only be detected by comparing the bulk characteristics of
that formulation to its surface properties, indicating the need of
surface analysis for ternary solid dispersions.
Information on both phase behaviour and spatial drug
distribution is indispensable as these characteristics can be
decisive for the release characteristics of a solid dispersion.
For example, phase behaviour might influence the release, as
particles containing a poorly soluble drug in the form of
amorphous precipitates in the polymeric matrix are likely to
have a slower release compared to ideal glass solutions where
the drug is molecularly dispersed within a matrix. Spatial drug
distribution might also influence the performance of a solid
dispersion. For instance, enrichment of drug at the surface
results in an increased size or number of (amorphous) drug
domains at the surface. This jeopardizes the increased solu-
bility originating from the (molecular) dispersion of the poorly
soluble drug. In that way surface-bulk distribution of the drug
will determine the release kinetics of the sample. Additionally
surface enrichment of an amorphous drug makes the solid
dispersion more prone to surface crystallization and therefore
might be detrimental to its stability. These issues highlight why
surface characterization of solid dispersions is crucial in un-
derstanding how they perform with respect to dissolution and
stability.
We have previously reported on the development of spray-
dried polymeric microspheres for intramuscular injection for
the long-term prophylaxis of infection with human immuno-
deficiency virus (HIV) [8, 9]. These shell structured micro-
spheres contain two biocompatible polymers, poly(lactic-co-
glycolic acid) (PLGA) and polyvinylpyrrolidone (PVP) and are
made up of a PLGA-rich surface layer and an underlying
PVP-rich phase [8]. MDSC analysis revealed, based upon
the Gordon-Taylor equation, that the polymeric micro-
spheres are estimated to consist of a PLGA-rich surface phase
(85% PLGA, 15% PVP) and a PVP-rich underlying phase
(97% PVP, 3% PLGA) [9].
For the present study a poorly soluble active pharmaceuti-
cal ingredient (API) was dispersed in these microspheres as a
solid dispersion. The model drug used was an HIV protease
inhibitor. Three model formulations with varying ratios of
API/PLGA/PVP were developed. As mentioned above, after
inclusion of the API the composition of the mixed phases
cannot be determined by (M)DSC. To discern the distribution
of the API in the microspheres and thus the ternary solid
dispersions, MDSC was combined with surface analysis tech-
niques, namely ToF-SIMS and AFM. The potential of this
combination lies in the complementarity of the techniques.
(M)DSC is a bulk thermo-analytical technique, whereas ToF-
SIMS is a surface mass spectrometry technique capable of
analyzing the top 1–2 nm. AFM enables spatial characteriza-
tion of topographic and mechanical properties of a sample
surface at nanoscale resolution.
For ToF-SIMS analysis, chemical identification of different
compounds at the sample surface is based upon the detection
of secondary ions, including molecular species or fragments
derived from these compounds. Besides chemical identifica-
tion, this technique can also provide information on spatial
distribution of compounds at the sample surface via ToF-
SIMS chemical imaging. The utility of ToF-SIMS for the
analysis of solid dispersions lies mainly in its potential to reveal
the spatial distribution of drug and excipient at the sample
surface [9–12]. Evidently, this information is indispensable for
complete characterization of solid dispersions. Homogeneous
mixing, at least at the resolution of the ToF-SIMS data (on the
order of microns) is assessed by uniformity of the drug and
polymer distribution at the sample surface.
The main contribution of AFM for the analysis of solid
dispersions lies in its potential to spatially resolve the phase
separation at nanoscale resolution [9, 13–16]. Although this
technique is not yet that frequently used for the characteriza-
tion of pharmaceutical samples, it exhibits great potential as
various mechanical properties (eg. stiffness, adhesion and fric-
tion) can be monitored to distinguish different compounds.
This study aims to clarify drug distribution in a multi-
phased polymeric system. To do so, for the first time, MDSC
was combined with ToF-SIMS and AFM to characterize the
phase behaviour of ternary solid dispersions.
EXPERIMENTAL SECTION
Materials
Poly(lactic-co-glycolic acid) (PLGA) (lactide:glycolide molar
ratio of 75:25, inherent viscosity of 0.2 dL/g) was purchased
from PURAC Biomaterials (Gorinchem, The Netherlands).
Polyvinylpyrrolidone K30 (PVP K30) (MW 44–54 kDa) was
kindly donated by BASF (Ludwigshafen, Germany). The API
was a poorly soluble HIV protease inhibitor provided by
Janssen (Beerse, Belgium) and its structure is shown in Fig. 1.
Dichloromethane (DCM) was provided by Fisher Scientific
(Leicestershire, United Kingdom).
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Methods
Spray Drying
Three model ternary solid dispersions made up of API, PLGA
and PVP were prepared by spray drying and had the follow-
ing composition: 10/75/15, 20/50/30 and 30/25/45 wt%
API/PLGA/PVP. Samples were spray dried with a Micro
Spray lab scale spray dryer (ProCepT, Zelzate, Belgium)
starting from a 5% feed solution in DCM. The inlet temper-
ature was set to 115°C and the feed rate was 6 mL/min. The
co-current drying air had a flow rate of 0.2 m3/min and the
atomizing air was supplied with a pressure of 1.25 bar.
Modulated Differential Scanning Calorimetry
The bulk miscibility behaviour of the spray-dried micro-
spheres was determined by MDSC (Q2000, TA Instruments,
Leatherhead, UK). Thermal Analysis Software (Version 4.4A)
was used to analyze the obtained data. Crimped aluminum
pans (TA Instruments, Brussels, Belgium) were selected for the
analysis of the samples. An empty pan was used as a reference
and the masses of the reference pan and of the sample pans
were taken into account. The DSC cell was purged with a
nitrogen flow rate of 50 mL/min.
Indium and octadecane were chosen for temperature cal-
ibration. The enthalpic response was calibrated with indium.
The modulation parameters used were a heating rate of 1°C/
min, a period of 40 s and an amplitude of 1°C. Calibration of
the heat capacity was done using sapphire. Samples were
analyzed from −20 to 220°C. Glass transitions were analyzed
in the reversing heat flow signals.
Scanning Electron Microscopy
SEM was used to study the morphology and particle size of
the samples which were prepared by fixing an amount of
powder on an aluminum stub using double-sided carbon tape.
The samples were coated with a gold-palladium mixture by
sputtering for 45 s at 20 mA. Field emission gun scanning
electron micrographs (FEG-SEM) were taken by using a
Philips XL30 ESEM-FEG instrument (Philips, Eindhoven,
The Netherlands) at an acceleration voltage of 10 kV.
Time-of-Flight Secondary ion Mass Spectrometry
Spray-dried samples were adhered to double-sided adhesive
tape in order to produce an immobile surface suitable for
ToF-SIMS analysis. The data were acquired using a ToF-
SIMS IV instrument (ION-TOF GmbH) equipped with a
bismuth liquid metal ion gun and a single-stage reflectron
analyzer. Typical operating conditions utilised a 25 kV Bi3
+
primary ion source with a pulsed target current of approxi-
mately 0.3 pA. A flood gun producing low energy electrons
(20 eV) was used to compensate for surface charging caused
by the positively charged primary ion beam on the insulating
sample surface. A 4 mm×4 mm area of each sample was
raster scanned at a resolution of 100 pixels per mm. PLGA
and PVP were identified using C6H7O4
− (m/z=143), and
C5H8O
− (m/z=84) respectively. The API was characterized
by C8H7SO3
− (m/z=183). Prior to sample analysis, reference
materials were analyzed and the characteristic ion peaks
C6H7O4
−, C5H8O
− and C8H7SO3
− were selected and only
present in PLGA, PVP and API respectively. Negative polar-
ity ToF-SIMS spectra showing the markers for API, PLGA
and PVP are shown in Fig. 1 of the Supplementary Informa-
tion. Static conditions were ensured by keeping the total
primary ion beam dose for every analyzed area below 1×
1012 ions/cm2 throughout the analysis. Data in the negative
secondary ion polarities were collected and analyzed using
SurfaceLab 6 software (IONTOF). For any given sample, the
measured secondary ion intensity for each polymer and API
marker peak was normalized to the total intensity count to
enable a semi-quantitative comparison of the different
samples.
Atomic Force Microscopy
The spray-dried powders were applied onto a fresh mica
surface using a Gilson pipette tip, and slightly blown with
pressured nitrogen gas. Freshly cleaved mica (Agar Scientific,
FIGURE 1 Structural formula of
the API, a poorly soluble HIV
protease inhibitor.
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Stansted, U.K.) was used as sample substrate. Samples were
imaged with a Bruker Dimension FastScan Bio AFM in
PeakForce Quantitative Nano-Mechanics (QNM) mode
(Bruker UK Ltd, Coventry, UK). Tap150A (also called as
MPP-12120, Bruker) tips (5 N/m, 150 kHz, rotated tip,
aluminum reflective coating) were used for PeakForce
imaging.
PeakForce QNM is a novel development in AFM tech-
niques. Whilst the tip is driven oscillated at its resonant fre-
quency in the traditional Tapping mode, the tip taps the
sample surface at a frequency substantially lower than its
resonant frequency in PeakForce mode, for example, 2 vs
150 kHz in the present case. The vertical position of the
AFM tip is maintained under continuous active control
allowing an accurate constant maximum contact force whilst
maintain nanoscale spatial resolution [17]. The active canti-
lever control allows a simultaneous extraction of quantitative
information related to surface properties such as stiffness and
adhesion alongside the traditional topographic data [18]. To
calculate sample stiffness from the tip-sample interaction force
data the Hertzian based DMT (Derjaguin-Muller-Toporov)
model was applied which assumes the contact is between a
rigid sphere (the silicon AFM tip apex) and a soft flat surface
(the polymeric microparticle). Gwyddion software (version
2.22) was used for data analysis.
RESULTS
Morphological Characterization of Microspheres
The particle size and surface morphology of the microspheres
of the different formulations were compared via SEM. Al-
though a statistically significant number of particles were not
analyzed, SEM could be used as an indicator for both particle
size and morphology. Figure 2 shows that there are no striking
differences regarding particle size and morphology when
comparing the three model formulations. Particles are spher-
ical, with a smooth, intact surface and an estimated diameter
approximately between 1 and 7 μm.
Phase Behaviour
MDSCwas used to determine the Tgs of the pure compounds,
which were 38°C for PLGA, 56°C for the API and 174°C for
PVP under the given experimental conditions. The phase
behaviour of the model formulations was examined and the
resulting thermograms are displayed in Fig. 3. For each sam-
ple two mixing Tgs were observed, the first one approximating
to the Tg of PLGA and the second one shifting towards the Tg
of pure PVP (Fig. 3). The known Tg of the API (around 56°C)
was not observed in the thermograms.
Surface Chemical Analysis
ToF-SIMS was used to chemically analyze the surfaces of the
microspheres and hence solid dispersions. The spatial distri-
bution of the API and PLGA at the sample surface is repre-
sented in Fig. 4. There is a negligible amount of PVP observed
at the particle surface which is consistent with previous studies
[8, 9] and depicted in Fig. 2 of the Supplementary Informa-
tion. At the micron-scale resolution of the ToF-SIMS data the
drug seems to be homogeneously distributed at the surface of
the three model formulations. For the formulation containing
20 wt% API a significantly higher intensity for the marker of
the API is observed.
Figure 5 illustrates the measured API intensity at the sam-
ple surface and hence depicts a measure of API surface cov-
erage for the three model formulations. Ranking of the for-
mulations based upon the observed API surface coverage is as
follows: 30/25/45<10/75/15<20/50/30 API/PLGA/PVP
wt%, whereas ranking based upon total API content is: 30/
25/45>20/50/30>10/75/15 API/PLGA/PVP wt%.
Hence the appearance of API at the particle surface is not in
agreement with the total amount of API present in the micro-
particles, e.g. formulation 30/25/45 API/PLGA/PVP wt%
has the highest bulk concentration of API (30 wt%) but shows
the lowest surface coverage compared to the other model
formulations.
Surface Topographical Analysis
Simultaneous mapping of topography and surface properties
using QNM in PeakForce mode revealed the surface structure
of the three formulations. Figures 6, 7 and 8 show topography
(3D and 2D views) along with the corresponding stiffness map
for the microspheres of the 10/75/15, 20/50/30 and 30/25/
45 API/PLGA/PVP wt% samples. The 3D data emphasize
that these images are acquired from the apex of immobilized
microspheres. The 2D representation following the back-
ground subtraction of the image curvature reveals surface
structure in details. For the 10 and 30 wt% API samples little
surface topographic variation is observed with a smooth ho-
mogeneous surface evident (Figs. 6A–B, 8A–B). The 20 wt%
API sample shows significant heterogeneity in surface topog-
raphy (Fig. 7A–B). Similarly the corresponding stiffness maps
only show significant heterogeneity in the 20 wt% API sample
(Figs. 6C, 7C and 8C).
DISCUSSION
MDSC was used to thermally study the phase behaviour of
the three model formulations. For each sample twomixingTgs
were observed, the first one approximating to the Tg of PLGA
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and the second one shifting towards the Tg of pure PVP
(Fig. 3). In addition, the absence of a Tg around 56°C (Tg of
the API) indicates that the API is molecularly dispersed in a
phase separated system made up of a PLGA-rich phase and a
PVP-rich phase. Preceding work has already revealed that
hollow spheres are formed when PLGA and PVP are spray-
dried together with a PLGA surface layer and an underlying
PVP layer [8, 9]. The presence of PLGA at the particle surface
is due to its surface activity and a consequence of restructuring
of the methyl side groups of PLGA towards the droplet-air
surface [8, 19]. Moreover these two polymeric phases display
a small degree of miscibility which is determined by the PLGA
to PVP ratio [8]. The additional presence of an API will
influence this phase behaviour.
Phase behaviour of the polymeric PLGA/PVP matrix was
studied by estimating the polymer miscibility in these binary
systems based upon the observed Tgs using the Gordon-
Taylor equation for binary mixtures (Eq. 1) [7].
T gmix ¼ w1T g1 þ Kw2T g2
 .
w1 þ Kw2ð Þ ð1Þ
In this equation, the weight fraction of each compound is
represented by w, the glass transition temperature by Tg and
the subscripts 1 and 2 represent the compounds with the
lowest and the highest glass transition temperatures respec-
tively. The constant K can be assessed by using the Simha-
Boyer rule (Eq. 2), with ρ being the density of the amorphous
compounds.
K ≈ ρ1T g1
 .
ρ2T g2
  ð2Þ
Consequently the amount of PVP present in the PLGA
layer and the amount of PLGA present in the PVP layer could
be calculated. The PVP content in the PLGA phase was thus
estimated to be 15% and the PLGA content in the PVP phase
3% [9].
The complex phase behaviour of ternary, or even quater-
nary (when taking residual solvent into account), systems is
however difficult, if not impossible to assess using this equa-
tion. An extended form of the Gordon-Taylor equation for
ternary mixtures has been developed (Eq. 3).
T gmix ¼ w1T g1 þ K 1w2T g2 þ K 2w3T g3
 
= w1 þ K 1w2 þ K 2w3ð Þ
ð3Þ
With w representing the weight fraction of each com-
pound, Tg the glass transition where the subscripts 1, 2 and 3
represent the compounds with the lowest, middle and the
highest glass transition temperatures, respectively. The con-
stants K1 and K2 are analogously obtained:
K 1≈ ρ1T g1
 .
ρ2T g2
 
and K 2≈ ρ1T g1
 .
ρ3T g3
 
FIGURE 2 Scanning electron
micrographs of the model
formulations with following API/
PLGA/PVP (w/w/w) ratios: (a). 10/
75/15, (b). 20/50/30 and (c). 30/
25/45.
FIGURE 3 MDSC of the model
formulations. From top to bottom
reversing heat flow with following
API/PLGA/PVP (w/w/w) ratios: (a).
10/75/15, (b). 20/50/30 and (c).
30/25/45.
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This extended formula was originally used to account
for residual (plasticizing) solvent [20–22] and was ex-
panded to the analysis of ternary solid dispersions [23].
However, this extended form finds limited application
due to the contradiction between the complexity of
ternary mixtures and the assumptions made for this
model equation. Generally the Gordon-Taylor equation
assumes additivity of the specific volumes of the com-
pounds involved as well as a linear change in volume
with temperature [6]. Obviously the likelihood that
FIGURE 4 ToF-SIMS secondary ion intensity images of the model formulations with the following API/PLGA/PVP (w/w/w) ratios: (a). 10/75/15, (b). 20/50/30,
(c). 30/25/45. Panels a show results of the total intensity signal. Panels b and c show negative polarity images of respectively API (m/z=183) and PLGA (m/z=
142). Panels d show the negative polarity overlay images (PVP in red, PLGA in green) (4 mm×4 mm scan size).
FIGURE 5 I. Negative ToF-SIMS
spectra at m/z 183 (marker API) of
the model formulations with the
following API/PLGA/PVP (w/w/w)
ratios: (a). 10/75/15, (b). 20/50/30,
(c). 30/25/45. II. Histogram
representing the intensity at m/z
183 for the three model
formulations (1 mm×1 mm scan
size, n=4).
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those assumptions apply decreases with increasing com-
plexity of the system.
The above indicates that (M)DSC alone does not allow the
determination of the ternary composition of the two phases
FIGURE 6 PeakForceQNMAFM
analysis of a spray-dried 10/75/15
API/PLGA/PVP particle. (a). 3D
representation of the AFM topo-
graphic data showing a region of the
particle displaying a smooth fea-
tureless surface, (b). 2D represen-
tation of the topographic data (fol-
lowing flattening of the data (vertical
grey scale 4 nm)) and (c). a corre-
sponding sample stiffness map
(based upon DMTanalysis, lighter
being stiffer (arbitrary scale)).
FIGURE 7 PeakForceQNMAFM
analysis of a spray-dried 20/50/30
API/PLGA/PVP particle. (a). 3D
representation of the AFM
topographic data showing a region
of the particle displaying clear
heterogeneity including surface
depressions, (b). 2D representation
of the topographic data (following
flattening of the data (vertical grey
scale 30 nm)) and (c). a
corresponding sample stiffness map
(based upon DMTanalysis, lighter
being stiffer (arbitrary scale)).
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present and is not sufficient to characterize these complex
ternary system samples as it is unable to inform on the distri-
bution of the API in the PLGA-rich surface layer and the
underlying PVP-rich phase. Owing to this limitation, for these
systems MDSC must be applied in combination with surface
analysis in order to determine the composition.
ToF-SIMS was utilised to chemically elucidate the surface
composition of the microspheres of the different formulations.
Chemical surface analysis by ToF-SIMS revealed that the
degree of API surface coverage of the solid dispersion clearly
differed when formulation parameters were changed (Figs. 4
and 5). Additionally, an inconsistency was observed between
the API bulk concentration and surface coverage. The sample
with the highest total amount of API (30/25/45 API/PLGA/
PVP wt%) did not show the highest amount of API present at
the surface, in fact it displayed the lowest surface coverage.
This discrepancy indicates that the API distribution of the
drug is influenced by formulation parameters. The observed
susceptibility of these systems regarding API distribution in-
duced by changes in formulation (and likely process)
parameters indicates the need for in depth sample character-
ization, combining miscibility, characterization of API surface
coverage and spatial API distribution at higher resolution.
AFM imaging of the three samples showed identifiable
differences between the appearance and organization of the
formulations. In general, spray-dried particles of the 10/75/
15 API/PLGA/PVP wt% formulation showed a smooth fea-
tureless topography with no evidence of sample heterogeneity.
Corresponding surface stiffness maps also indicated a homog-
enous material with no significant nanoscale variation in me-
chanical properties (Fig. 6). Similar observations were also
made for the 30/25/45 API/PLGA/PVP wt% samples. Al-
though particles did show some circular topographic features
no significant variation in mechanical properties was observed
(Fig. 8), again indicating a compositionally homogeneous
surface. In contrast, the 20/50/30 API/PLGA/PVP wt%
formulation showed some significant heterogeneity in its sur-
face topography and composition. There is clear evidence of
pits in the surface of the order of hundreds of nanometers in
diameter and 2–15 nm in depth. The stiffness map shows
FIGURE 8 PeakForceQNMAFM
analysis of a spray-dried 30/25/45
API/PLGA/PVP particle. (a). 3D
representation of the AFM
topographic data showing a region
of the particle displaying a relatively
smooth surface with some circular
features, (b). 2D representation of
the topographic data (following
flattening of the data (vertical grey
scale 300 nm)) and (c). a
corresponding sample stiffness map
(based upon DMTanalysis, lighter
being stiffer (arbitrary scale)). Note
the small triangular indents at the
top of the image are due to a high
force threshold during the AFM tip’s
raw engagement.
FIGURE 9 Elucidated structures
of the model formulations with
following API/PLGA/PVP (w/w/w)
ratios: (a). 10/75/15, (b). 20/50/30
and (c). 30/25/45.
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areas of reduced stiffness (darker contrast) in relation to the
majority of the surface, sometimes but not always associated
with the pits (Fig. 7). Whilst AFM does not uniquely
(chemically) identify components as in ToF-SIMS the obser-
vation of complexity at the surface of the 20/50/30 as com-
pared to the 10/75/15 and 30/25/45 API/PLGA/PVP wt%
samples is consistent with the 20 wt% API samples showing in
Tof-SIMS data a higher than expected ratio of API at the
surface of the particles. Hence the structural pits imaged by
the AFMmay be revealing underlying material that contains a
higher proportion of API than over the rest of the surface
and/or that surface heterogeneity (incomplete mixing of com-
ponents) in these samples is related to the higher API surface
coverage.
The information regarding the phase behaviour of the
polymers obtained by MDSC was combined with the infor-
mation ToF-SIMS provided on the spatial distribution of the
API at the surface of the microspheres as well as on the
ranking of the formulations based on API surface coverage.
AFM provided spatial information on the distribution of
different compounds at the microsphere surface at nanoscale
resolution. Taken together these techniques provide insights
into differences in drug distribution (via the observed surface
coverage) for three differently composed ternary solid disper-
sions. A schematic illustration of the elucidated structures of
the three model formulations is shown in Fig. 9.
The observed differences between the formulations studied
can be explained by the fact that a change in formulation
parameters (here a change in the ratio API/PLGA/PVP and
thus composition of the feed solution) can influence particle
formation during spray drying. A differently composed feed
solution can result in different feed viscosity, evaporation rate
or solidification point of the compounds. These parameters
might affect the distribution of the API in the formed micro-
spheres and therefore the degree of API surface coverage.
This is illustrated by the Peclet number (Pe) which is used to
predict compound distribution of the API during the particle
formation process (Eq. 4).
Pei ¼ κ
.
8Di ð4Þ
In this equation the evaporation rate is represented by ĸ
and Di stands for the diffusion coefficient of solute i. This
formula clearly indicates how a change in evaporation rate
might influence API distribution. Evaporation rate can be
influenced by a varying feed composition as the affinity be-
tween solvent-polymer and solvent-drug molecules influences
the evaporation rate. The extent of this influence will depend
on the amount of polymer or drug molecules (with affinity for
the solvent) present in solution [24]. The potential influence of
feed viscosity on API distribution and (surface coverage) is
illustrated by the Stokes-Einstein equation which pinpoints the
different parameters that influence the diffusion coefficient of
a compound (Eq. 5).
D ¼ kBT
.
6πηr ð5Þ
In this equation D is the diffusion coefficient, r the globular
radius, T the absolute temperature and η the viscosity of the
solution. kB is the Boltzmann constant.
The higher the concentration of a compound in the feed
solution, the closer it will be to its solubility limit and the faster
it will reach the solidification point during the particle forma-
tion process. This possible difference of solute deposition time
might also influence the spatial distribution of the API [25].
The lack of substantial differences in microspheres size and
morphology (Fig. 2) when comparing the three model formu-
lations indicates that differences in formulation parameters
did not influence particle size and morphology.
In addition to influencing the particle formation process,
changing the ratio of the three components might result in
different mixed phases each displaying different solubility of
the API and again a different distribution of the API in the
spray-dried microspheres.
CONCLUSIONS
This study demonstrated how a combination of MDSC and
the surface analysing techniques ToF-SIMS and AFM offer
synergistic benefits for the characterisation of the phase be-
haviour and drug distribution of ternary solid dispersions
(API/PLGA/PVP).
MDSC showed that the investigated formulations consisted
of two mixed phases, a PLGA-rich phase and a PVP-rich
phase, in which the API is present as a glass solution. ToF-
SIMS informed on the spatial composition of the ternary solid
dispersions: the PLGA-rich phase covers the surface of the
microspheres, the PVP-rich phase is situated underneath. The
degree of API surface coverage varies for the different formu-
lations but is not in agreement with the bulk API concentra-
tion. AFM imaging and mechanical mapping coupled nano-
scale spatial information about the microsphere surface to
these findings, indicating structural and compositional hetero-
geneity in the 20 wt% API samples (compared to 10 and
30 wt% API samples), which was consistent with their higher
than expected surface coverage of API.
Interestingly, the distribution of the API in the ternary solid
dispersions depended on formulation parameters. The extent
of API surface coverage and therefore the distribution of the
API over both polymeric phases differed significantly for the
three formulations. As the location of the API in the
Combination of (M)DSC and Surface Analysis to Study the Phase 1415
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microspheres might significantly influence the performance of
the formulation (release behaviour and physical stability) in-
sight into how formulation and process parameters influence
the spatial distribution of the drug in these ternary solid
dispersions would allow rational design of control release
profiles and stability performance.
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